Toggle navigation
TITIN
db
2
Home
Search
Variant Converter
Tutorials
Documentation
Downloads
Domain:
Fn3-1
Kinase-1
Ig-1
Ig-2
Fn3-2
Ig-3
Fn3-3
Fn3-4
Ig-4
Fn3-5
Ig-5
Fn3-6
Ig-6
Fn3-7
Ig-7
Fn3-8
Ig-8
Ig-9
Fn3-9
Fn3-10
Ig-10
Fn3-11
Ig-11
Fn3-12
Ig-12
Fn3-13
Ig-13
Fn3-14
Ig-14
Fn3-15
Ig-15
Ig-16
Fn3-16
Ig-17
Fn3-17
Fn3-18
Ig-18
Fn3-19
Ig-19
Ig-20
Fn3-20
Fn3-21
Ig-21
Fn3-22
Ig-22
Fn3-23
Ig-23
Fn3-24
Ig-24
Ig-25
Fn3-25
Ig-25_novex3
Ig-26
Fn3-26
Ig-26_novex3
Fn3-27
Ig-27
Ig-27_novex3
Fn3-28
Ig-28
Ig-28_novex3
Ig-29
Fn3-29
Ig-29_novex3
Fn3-30
Ig-30
Ig-30_novex3
Ig-31
Fn3-31
Ig-32
Fn3-32
Ig-33
Fn3-33
Ig-34
Fn3-34
Ig-35
Fn3-35
Ig-36
Fn3-36
Ig-37
Fn3-37
Ig-38
Fn3-38
Ig-39
Fn3-39
Ig-40
Fn3-40
Ig-41
Fn3-41
Ig-42
Fn3-42
Ig-43
Fn3-43
Ig-44
Fn3-44
Ig-45
Fn3-45
Ig-46
Fn3-46
Ig-47
Fn3-47
Ig-48
Fn3-48
Ig-49
Fn3-49
Ig-50
Fn3-50
Ig-51
Fn3-51
Ig-52
Fn3-52
Ig-53
Fn3-53
Ig-54
Fn3-54
Ig-55
Fn3-55
Ig-56
Fn3-56
Ig-57
Fn3-57
Ig-58
Fn3-58
Ig-59
Fn3-59
Ig-60
Fn3-60
Ig-61
Fn3-61
Ig-62
Fn3-62
Ig-63
Fn3-63
Ig-64
Fn3-64
Ig-65
Fn3-65
Ig-66
Fn3-66
Ig-67
Fn3-67
Ig-68
Fn3-68
Ig-69
Fn3-69
Ig-70
Fn3-70
Ig-71
Fn3-71
Ig-72
Fn3-72
Ig-73
Fn3-73
Ig-74
Fn3-74
Ig-75
Fn3-75
Ig-76
Fn3-76
Ig-77
Fn3-77
Ig-78
Fn3-78
Ig-79
Fn3-79
Ig-80
Fn3-80
Ig-81
Fn3-81
Ig-82
Fn3-82
Ig-83
Fn3-83
Ig-84
Fn3-84
Ig-85
Fn3-85
Ig-86
Fn3-86
Ig-87
Fn3-87
Ig-88
Fn3-88
Ig-89
Fn3-89
Ig-90
Fn3-90
Ig-91
Fn3-91
Ig-92
Fn3-92
Ig-93
Fn3-93
Fn3-94
Ig-94
Ig-95
Fn3-95
Fn3-96
Ig-96
Ig-97
Fn3-97
Ig-98
Fn3-98
Fn3-99
Ig-99
Ig-100
Fn3-100
Ig-101
Fn3-101
Ig-102
Fn3-102
Fn3-103
Ig-103
Fn3-104
Ig-104
Ig-105
Fn3-105
Ig-106
Fn3-106
Fn3-107
Ig-107
Ig-108
Fn3-108
Fn3-109
Ig-109
Fn3-110
Ig-110
Ig-111
Fn3-111
Ig-112
Fn3-112
Fn3-113
Ig-113
Fn3-114
Ig-114
Fn3-115
Ig-115
Fn3-116
Ig-116
Fn3-117
Ig-117
Fn3-118
Ig-118
Fn3-119
Ig-119
Ig-120
Fn3-120
Ig-121
Fn3-121
Fn3-122
Ig-122
Fn3-123
Ig-123
Ig-124
Fn3-124
Ig-125
Fn3-125
Fn3-126
Ig-126
Ig-127
Fn3-127
Ig-128
Fn3-128
Ig-129
Fn3-129
Ig-130
Fn3-130
Ig-131
Fn3-131
Ig-132
Fn3-132
Ig-133
Ig-134
Ig-135
Ig-136
Ig-137
Ig-138
Ig-139
Ig-140
Ig-141
Ig-142
Ig-143
Ig-144
Ig-145
Ig-146
Ig-147
Ig-148
Ig-149
Ig-150
Ig-151
Ig-152
Ig-153
Ig-154
Ig-155
Ig-156
Ig-157
Ig-158
Ig-159
Ig-160
Ig-161
Ig-162
Ig-163
Ig-164
Ig-165
Ig-166
Ig-167
Ig-168
Ig-169
Disease: AVB
Position
Domain
Domain position
SNV
RS
Source
Comments
MAF
Zygosity
Structural Position
AlphaMissense (IC)
REVEL
Rhapsody
DUET
PolyPhen-2
Condel
Q(SASA)
Site annotation
mCSM PPI
Predicted PPI site
AFR
AMR
EAS
EUR
FIN
NFE
SAS
16429
Fn3-6
79
N/K
rs763809932
Liu (2020)
WES prioritisation in single AVB family; co-segregates with disease phenotype (n = 5, 5 affected (7 total))
None
het
112
0.9996
0.556
0.763
None
1.0
None
0.0863
None
None
N
None
None
None
None
None
None
None